ADNP Antibody (6B8) Summary
ADNP (NP_056154, 1018 a.a. ~ 1103 a.a) partial recombinant protein with GST tag. TMQGDREQLKWKNSSYGKVEGFWSKDQSQWKNASENDERLSNPQIEWQNSTIDSEDGEQFDNMTDGVAEPMHGSLAGVKLSSQQA
Nuclear
ADNP – activity-dependent neuroprotector
IgG3 Kappa
Monoclonal
Mouse
ADNP
IgG purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Western Blot 1:500
- ELISA
Antibody Reactive against Recombinant Protein with GST tag on ELISA and Western Blot. GST tag alone is used as a negative control.
Reactivity Notes
Human. Other species not tested.
Packaging, Storage & Formulations
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Phosphate buffered saline, pH 7.4
No Preservative
IgG purified
Notes
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for ADNP Antibody (6B8)
- Activity-dependent neuroprotective protein
- activity-dependent neuroprotector homeobox
- activity-dependent neuroprotector
- ADNP homeobox 1
- ADNP
- ADNP1
- ADNP1KIAA0784activity-dependent neuroprotector homeobox protein
Background
Vasoactive intestinal peptide is a neuroprotective factor that has a stimulatory effect on the growth of some tumor cells and an inhibitory effect on others. This gene encodes a protein that is upregulated by vasoactive intestinal peptide and may be involved in its stimulatory effect on certain tumor cells. The encoded protein contains one homeobox and nine zinc finger domains, suggesting that it functions as a transcription factor. This gene is also upregulated in normal proliferative tissues. Finally, the encoded protein may increase the viability of certain cell types through modulation of p53 activity. Alternatively spliced transcript variants encoding the same protein have been described.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets : PI4K_Akt_mTOR inhibitors